Replies to post #520909 on NorthWest Biotherapeutics Inc (NWBO)

[extrooper]

Correction “most traders do not gave any brains to know when to hold”

[FeMike]

We all know why NW stock was hammered after 5/10/22.

NWBO was hammered during NYAS because the very first slide showing results, which has been anticipated for years, said:

PFS was not significantly different between the DCVax-L arm and placebo arm: p=0.47

That's it. It was very poorly presented from an investor perspective.

There were foul players involved as well, no doubt, but their efforts could have easily been negated had NWBO:

1) Changed the endpoints on clinicaltrials.gov as soon as they finished the SAP
2) Presented the new, successful endpoints first rather than the old, (pseudo)failed endpoints.

That's all it would have taken, and we'd still be trading above $2 and likely higher, thus reducing dilution, while waiting for the next big event. But NWBO management are a bunch of limp wristed, weak minded buffoons.

[sukus]

Thanks Roman516

[HyGro]

Investors didn't buy the TLD. Still aren't buying it as share price has shown ZERO positive response from the TLD data. Biotechs with positive clinical trial results in virtually every case have positive share price movement -- but for NWBO -- Nothing.